scispace - formally typeset
Journal ArticleDOI

Gender-specific differences in clinical outcome of primary prevention implantable cardioverter defibrillator recipients

Reads0
Chats0
TLDR
Women have lower mortality and tend to experience less appropriate ICD therapy as compared with their male peers, and 21% of primary prevention ICD recipients are women.
Abstract
Objective To assess differences in clinical outcome of implantable cardioverter-defibrillator (ICD) treatment in men and women. Design Prospective cohort study. Setting University Medical Center. Patients 1946 primary prevention ICD recipients (1528 (79%) men and 418 (21%) women). Patients with congenital heart disease were excluded for this analysis. Main outcome measures All-cause mortality, ICD therapy (antitachycardia pacing and shock) and ICD shock. Results During a median follow-up of 3.3 years (25th–75th percentile 1.4–5.4), 387 (25%) men and 76 (18%) women died. The estimated 5-year cumulative incidence for all-cause mortality was 20% (95% CI 18% to 23%) for men and 14% (95% CI 9% to 19%) for women (log rank p Conclusions In clinical practice, 21% of primary prevention ICD recipients are women. Women have lower mortality and tend to experience less appropriate ICD therapy as compared with their male peers.

read more

Citations
More filters
Journal ArticleDOI

Sex Differences in Cardiac Electrophysiology and Clinical Arrhythmias: Epidemiology, Therapeutics, and Mechanisms

TL;DR: Current knowledge regarding the nature and underlying mechanisms of sex differences in basic cardiac electrophysiology and clinical arrhythmias is reviewed.
Journal ArticleDOI

Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: Findings from the National Cardiovascular Data Registry (NCDR)

TL;DR: Among older patients receiving ICDs for primary prevention in clinical practice, women experience worse outcomes than do men, and reasons for gender differences in outcomes are poorly understood and require further investigation.
Journal ArticleDOI

The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications.

TL;DR: After long-term follow-up of ICD (12 years) and CRT-D (8 years) recipients, 49% of I CD recipients and 55% of CRT’s recipients had died and appropriate defibrillator therapy was received by the majority and by almost 40% of recipients.
Journal ArticleDOI

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population

Jens Cosedis Nielsen, +52 more
TL;DR: This expert consensus statement task force was set down to raise awareness of using the right risk assessment tool for a given outcome in a given population, and to provide physicians with practical proposals that may lead to rational and evidence-based risk assessment and improvement of patient care in this regard.
References
More filters
Journal ArticleDOI

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

TL;DR: In patients with a prior myocardial infarction and advanced left ventricular dysfunction, prophylactic implantation of a defibrillator improves survival and should be considered as a recommended therapy.
Journal ArticleDOI

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

TL;DR: Among survivors of ventricular fibrillation or sustained ventricular tachycardia causing severe symptoms, the implantable cardioverter-defibrillator is superior to antiarrhythmic drugs for increasing overall survival.
Related Papers (5)